102 related articles for article (PubMed ID: 16569196)
1. Evidence of the capability of the CMV enhancer to activate in trans gene expression in mammalian cells.
D'Aiuto L; De Marco R; Edward N; Rizzo A; Chaillet JR; Montecalvo A; Lotze MT; Gambotto A
DNA Cell Biol; 2006 Mar; 25(3):171-80. PubMed ID: 16569196
[TBL] [Abstract][Full Text] [Related]
2. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87.
Grassi G; Maccaroni P; Meyer R; Kaiser H; D'Ambrosio E; Pascale E; Grassi M; Kuhn A; Di Nardo P; Kandolf R; Küpper JH
Carcinogenesis; 2003 Oct; 24(10):1625-35. PubMed ID: 12869421
[TBL] [Abstract][Full Text] [Related]
4. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
Weber EL; Cannon PM
Hum Gene Ther; 2007 Sep; 18(9):849-60. PubMed ID: 17767401
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
6. In trans promoter activation by enhancers in transient transfection.
Smirnov NA; Akopov SB; Didych DA; Nikolaev LG
Gene; 2017 Mar; 603():15-20. PubMed ID: 27956170
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of different viral promoters in directing gene expression in mammalian cells: effect of 3'-untranslated sequences.
Rotondaro L; Mele A; Rovera G
Gene; 1996 Feb; 168(2):195-8. PubMed ID: 8654943
[TBL] [Abstract][Full Text] [Related]
8. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
9. Trans-activation of the mouse cytomegalovirus immediate early gene enhancer by ras oncogenes.
Lembo D; Angeretti A; Foresta P; Gribaudo G; Gariglio M; Landolfo S
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1685-92. PubMed ID: 8021597
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice.
Mehta AK; Majumdar SS; Alam P; Gulati N; Brahmachari V
Gene; 2009 Jan; 428(1-2):20-4. PubMed ID: 18976699
[TBL] [Abstract][Full Text] [Related]
12. Efficient expression from one CMV enhancer controlling two core promoters.
Andersen CR; Nielsen LS; Baer A; Tolstrup AB; Weilguny D
Mol Biotechnol; 2011 Jun; 48(2):128-37. PubMed ID: 21113688
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence activated cell sorting of transiently transfected As4.1 cells shows renin enhancer directs on/off switching of renin promoter in vitro.
Morris BJ
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):367-71. PubMed ID: 18307722
[TBL] [Abstract][Full Text] [Related]
14. Efficient gene delivery into mammalian cells by recombinant baculovirus containing a hybrid cytomegalovirus promoter/Semliki Forest virus replicon.
Pan Y; Zhao Q; Fang L; Luo R; Chen H; Xiao S
J Gene Med; 2009 Nov; 11(11):1030-8. PubMed ID: 19757479
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of combined gene regulatory elements for transcriptional targeting of suicide gene expression to malignant melanoma.
Rothfels H; Paschen A; Schadendorf D
Exp Dermatol; 2003 Dec; 12(6):799-810. PubMed ID: 14714561
[TBL] [Abstract][Full Text] [Related]
16. Generation of stably transfected Mammalian cell lines as fluorescent screening assay for NF-kappaB activation-dependent gene expression.
Hellweg CE; Baumstark-Khan C; Horneck G
J Biomol Screen; 2003 Oct; 8(5):511-21. PubMed ID: 14567778
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of double gene construct for rapid identification of transgenic mice exhibiting tissue-specific gene expression.
Sato M; Watanabe T; Oshida A; Nagashima A; Miyazaki JI; Kimura M
Mol Reprod Dev; 2001 Dec; 60(4):446-56. PubMed ID: 11746955
[TBL] [Abstract][Full Text] [Related]
18. An enhancer/promoter combination strengthens the expression of blood-coagulation factor VIII in non-viral expression vectors.
Picanço-Castro V; Russo-Carbolante EM; Fontes AM; Fernandes AC; Covas DT
Genet Mol Res; 2008 Apr; 7(2):314-25. PubMed ID: 18551397
[TBL] [Abstract][Full Text] [Related]
19. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice.
Xu L; Daly T; Gao C; Flotte TR; Song S; Byrne BJ; Sands MS; Parker Ponder K
Hum Gene Ther; 2001 Mar; 12(5):563-73. PubMed ID: 11268288
[TBL] [Abstract][Full Text] [Related]
20. Hybrid cytomegalovirus enhancer-h1 promoter-based plasmid and baculovirus vectors mediate effective RNA interference.
Ong ST; Li F; Du J; Tan YW; Wang S
Hum Gene Ther; 2005 Dec; 16(12):1404-12. PubMed ID: 16390271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
